A groundbreaking study led by researchers from Washington University School of Medicine and Children’s Hospital of Philadelphia has identified a…
Read More

A groundbreaking study led by researchers from Washington University School of Medicine and Children’s Hospital of Philadelphia has identified a…
Read More
For more than six decades, metformin has served as the cornerstone of pharmacological management for type 2 diabetes. Since its…
Read More
The burgeoning market for obesity treatments, now valued at an astonishing $1 trillion, stands at a pivotal juncture. While GLP-1…
Read More
The landscape of artificial intelligence is undergoing a profound transformation, moving rapidly beyond the foundational large language models and simple…
Read More
Antibody-drug conjugates (ADCs) represent a significant leap forward in targeted cancer therapy, a sophisticated class of drugs that marries the…
Read More
Alzheimer’s disease remains one of the most significant challenges to modern medicine, currently affecting an estimated 7.2 million Americans age…
Read More
OrsoBio, a dynamic biotech enterprise dedicated to advancing novel therapies for obesity and a spectrum of obesity-related metabolic disorders, is…
Read More
The pursuit of groundbreaking innovation in advanced therapeutic medicinal products (ATMPs) is a high-stakes endeavor, particularly for early-stage biotech startups…
Read More